Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer - A Multicentric Phase III Prospective Randomized Controlled Trial

NCT07408999 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT07408999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07408999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer - A Multicentric Phase III Prospective Randomized Controlled Trial
Lead sponsor
University Hospital, Lille
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
March 31, 2031
Enrollment
327 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resecable esophageal or gastroesophageal junction cancer